PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Taewoong Medical Co., Ltd

USPTO PatentsView assignee record - 23 granted patents across 6 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Taewoong ranks #13,184 of 49,997 tracked US assignees by granted-patent volume, with 23 patents across 6 technology areas.

#13,184
of 49,997 US assignees by volume
Top 31%
by Innovation Score (42.2/100)
9.8
avg claims per patent
+30%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R13184 · Foreign Corporation #13,184 · 23 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-UP · BOOK-FULL

  • GRANTS-SMALL 23 grants
  • MID-PACK #13,184/49,997
  • PHOTO-FINISH Synexis
  • CPC-NARROW A61B · 6 areas
  • INNOV-PAR 42.2/100
  • CLAIMS-PAR 9.8 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-UP +30% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Synexis LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Taewoong’s 42.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Taewoong

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Taewoong's Innovation Score is 42.2/100 (top 31% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Taewoong?

Each dot is one of Taewoong’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Taewoong’s own 9.8 claims/patent is at or below the 14.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Taewoong vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 22.922.92323.1 510152025 Granted patents (volume) Avg claims / patent Synexis LLC - 23, 14.57SynexisSyntiant Corp. - 23, 18.35SyntiantSysdig, Inc. - 23, 19.35SysdigTABOOLA.COM Ltd. - 23, 20.35Taboola COMTaisho Pharmaceutical Co., Ltd. - 23, 12.78Taisho Pharmaceut…Takemoto Yushi Kabushiki Kaisha - 23, 8.7Takemoto YushiTeco Electric & Machinery Co., Ltd. - 23, 7.74Teco Electric & M…TGW Mechanics GmbH - 23, 23.04TGW MechanicsTaewoong Medical Co., Ltd - 23, 9.83Taewoong Medical
Taewoong vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Taewoong's grants concentrate

Taewoong Medical Co., Ltd is a focused PatentsView assignee: 6 CPC subclasses with 69.6% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (5 grants) versus a trough of 1 in 2018. By volume, Taewoong sits between Synexis LLC and TGW Mechanics GmbH.

Taewoong's three-year grant acceleration

Taewoong Medical Co., Ltd shows 10 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Taewoong's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Taewoong holds 23 patents at rank #13,177, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Taewoong

By rank, the assignees closest to #13,177 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Taewoong's primary technology class.

Taewoong's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 31% higher than 69% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 201520162017201820192020202120232024 5
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Taewoong Medical Co., Ltd patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 4 17.4%
2016 2 8.7%
2017 2 8.7%
2018 1 4.3%
2019 1 4.3%
2020 2 8.7%
2021 1 4.3%
2023 5 21.7%
2024 5 21.7%

Which technologies does Taewoong Medical Co., Ltd patent most?

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Taewoong Medical Co., Ltd's patent record in context - here's where to go next.

  • Taewoong Medical Co., Ltd's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 69.6% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #13,184 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Taewoong Medical Co., Ltd against Synexis LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 42.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.